Rapafusyn Pharmaceuticals is an emerging pharmaceutical development company located in Baltimore Maryland. Rapafusyn has licensed technology related to a novel class of natural product-like macrocycles from Johns Hopkins University School of Medicine and seeks to develop novel pharmaceuticals to treat patients having diseases and fulfill unmet medical needs.
Founded date: 2015
Investors 2
| Date | Name | Website |
| 07.06.2021 | 3E Biovent... | 3ebiovc.co... |
| - | Johns Hopk... | ventures.j... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 02.02.2024 | Rapafusyn's Rick Ewing Acknowledged with Dual Honors for Exc... | BALTIMORE, MARYLAND, USA, February 2, 2024 /EINPresswire.com/ -- Rapafusyn proudly announces the dis... | einpresswi... |